Apples and oranges? Interpreting success in HIV prevention trials

Contraception

Volumn 83, Issue 1, 2011, Pages 10-15

  Heise, Lori L ^a   Watts, Charlotte ^a   Foss, Anna ^a   Trussell, James ^b,c   Vickerman, Peter ^a   Hayes, Richard ^a   McCormack, Sheena ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF HULL   (United Kingdom)

^d MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

Contraception; Effectiveness; Efficacy; Family planning; HIV prevention; Microbicide; Vaccine

Indexed keywords

MICROBICIDE;

CLINICAL TRIAL; CONDOM; CONTRACEPTION; DECISION MAKING; EPIDEMIC; FAMILY PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MATHEMATICAL MODEL; REVIEW; RISK REDUCTION; TECHNOLOGY;

CLINICAL TRIALS AS TOPIC; CONDOMS; FAMILY PLANNING SERVICES; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; PATIENT COMPLIANCE; RISK;

EID: 78649906005     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.06.009     Document Type: Review

References (27)

1. Aids Vaccine Advocacy Coalition (AVAC) HIV prevention research: timeline of expected efficacy trial results 2010 AVAC New York
2. Mann J.R., Stine C.C., and Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom Sex Transm Dis 29 2002 344 349
3. Auvert B., Taljaard D., Lagarde E., Sobngwi-Tambekou J.l., Sitta Rm., and Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial PLoS Med 2 2005 e298
4. Bailey R.C., Moses S., and Parker C.B. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial Lancet 369 2007 643 656
5. Gray R.H., Kigozi G., and Serwadda D. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 2007 657 666
6. National Institutes of Health Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention 2001 National Institute for Allergy and Infectious Diseases (NIAID) Bethesda (MD)
7. Vijayakumar G., Mabude Z., Smit J., Beksinska M., and Lurie M. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence Int J STD AIDS 17 2006 652 659
8. Weller S., and Davis-Beatty K. Condom effectiveness in reducing heterosexual HIV transmission Cochrane Database Syst Rev 2002 CD003255
9. Weller S.C. A meta-analysis of condom effectiveness in reducing sexually-transmitted HIV Soc Sci Med 36 1993 1635 1644
10. Pinkerton S.D., and Abramson P.R. Effectiveness of condoms in preventing HIV transmission Soc Sci Med 44 1997 1303 1312
11. Trussell J. Contraceptive failure in the United States Contraception 70 2004 89 96
12. Gigerenzer G., and Edwards A. Simple tools for understanding risks: from innumeracy to insight BMJ 327 2003 741 744
13. Kaye K., Suellentrop K., and Sloup C. The fog zone: how misperceptions, magincal thinking and ambivalence put young adults at risk for unplanned pregnancy 2009 The National Campaign to Prevent Teen and Unplanned Pregnancies Washington, DC
14. Trussell J. Contraceptive efficacy R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, D. Kowal, Contraceptive technology. Ninetheenth Revised Edition 2007 Ardent Media New York (NY)
15. Foss A.M., Vickerman P.T., Heise L., and Watts C.H. Shifts in condom use following microbicide introduction: should we be concerned? AIDS 17 2003 1227 1237
16. Boily M.C., Baggaley R.F., and Wang L. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies Lancet Infect Dis 9 2009 118 129
17. Fraser A., Goldberg E., Acosta C.J., Paul M., and Leibovici L. Vaccines for preventing typhoid fever Cochrane Database Syst Rev 2007 CD001261
18. Horne A.D., Lachenbruch P.A., and Goldenthal K.L. Intent-to-treat analysis and preventive vaccine efficacy Vaccine 19 2000 319 326
19. Lee C., Gong Y., Brok J., Boxall E.H., and Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers Cochrane Database Syst Rev 2006 CD004790
20. Colvin M., Gorgens-Albino M., and Kasedde S. Analysis of HIV prevention response and modes of HIV transmission: the UNAIDS-GAMET supported synthesis process 2009 UNAIDS Geneva (Switzerland)
21. Foss A.M., Hossain M., Vickerman P.T., and Watts C.H. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia Sex Transm Infect 83 2007 510 516
22. Montgomery C.M., Gafos M., and Lees S. Re-framing microbicide acceptability: findings from the MDP301 trial Cult Health Sex 2010 1
23. Watts C., Foss A.M., Kumaranayake L., Cox A., Terris-Presholt F., and Vickerman P. Identifying optimal strategies for microbicide distribution in India and South Africa: modelling and cost-effectiveness analyses 2008 International Partnership for Microbicides Silver Spring (MD)
24. Amirfar S., Hollenberg J.P., and Abdool Karim S.S. Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa JAIDS 43 2006 219 225 10.1097/01.qai.0000230526.79341.83
25. Bogard E., and Kuntz K.M. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model JAIDS 29 2002 132 141
26. Supachai R.N., Pitisuttithum P., and Nitayaphan S. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2009 2209 2220
27. Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia Grade 2, Grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Lancet 369 2007 1861 1868